Alvotech and DKSH Extend their Collaboration to Commercialize Six Biosimilars in Asia
Shot:
- The companies expand their strategic partnership to commercialize six new biosimilar product candidates for the Asian markets
- In Mar’2020- the companies collaborated for AVT02 (biosimilar- adalimumab). The collaboration targets Taiwan- Korea- Hong Kong- Philippines- Vietnam- Thailand- Cambodia- Myanmar- Malaysia- Singapore- Indonesia- India- Bangladesh- and Pakistan
- The expansion deepens the partnership b/w the two companies to accelerate the introduction of a high-quality biosimilar to patients in Asia
Ref: Alvotech | Image: Alvotech
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com